Inovio Pharmaceuticals

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Manufacturer of prescription pharmaceutical products intended for patient care through transdermal drug delivery. The company is primarily focused on the areas of women's health and mental health, including ADHD and schizophrenia.

Manufacturer of pharmaceutical products and services intended to serve international health organizations, and public sectors. The company supplies several essential and lifesaving vaccines and pharmaceuticals and is committed to the prevention of hazards, risks and negative environmental impacts while developing, manufacturing, storing, handling and distributing its products, thereby enhancing mankind's ability to predict illness.